Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$2.26
-9.80%
Mkt Cap $415.79M
Analyst Ratings
Buy
2
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
Implied Upside
+624.2%
Consensus $16.33 vs current $2.26
NASDAQ·Healthcare·Biotechnology
$2.26
-9.80%
Mkt Cap $415.79M
Buy
2
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
+624.2%
Consensus $16.33 vs current $2.26